Journal of Antimicrobial Chemotherapy (2002) 49, 897-903
© 2002 The British Society for Antimicrobial Chemotherapy
Review |
Patient compliance with antibiotic treatment for respiratory tract infections
Department of Family Medicine, Medical University of dódû, 90-141 dódû, Poland
Despite doctors expectations, non-compliance is common in short-term antibiotic therapy of respiratory tract infections (RTIs). This phenomenon has profound practical implications. It leads to ineffective management, the deterioration of patients health, hospital admissions, additional costs and the emergence of antibiotic-resistant microorganisms. This article reviews methods of measuring compliance with antibiotics in the outpatient-based management of RTIs and research results. Causes of non-compliance are also discussed. Factors influencing compliance are analysed, as well as practical strategies for addressing non-compliance with antibiotic therapies for RTIs. The influence of the frequency of doses on compliance is particularly stressed, as it has been observed that once daily dosing has almost a 100% compliance rate. As a number of once-daily antibiotic preparations are available now, the possibility of using once-daily schedules for improving compliance in RTI cases is stressed.
* Tel: +48-42-678-72-10; Fax: +48-42-678-52-57; E-mail: pkardas{at}psk2.am.lodz.pl
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Llor, N. Sierra, S. Hernandez, A. Moragas, M. Hernandez, C. Bayona, and M. Miravitlles The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance J. Antimicrob. Chemother., February 1, 2009; 63(2): 396 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Hurdle, R. B. Lee, N. R. Budha, E. I. Carson, J. Qi, M. S. Scherman, S. H. Cho, M. R. McNeil, A. J. Lenaerts, S. G. Franzblau, et al. A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents J. Antimicrob. Chemother., November 1, 2008; 62(5): 1037 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Silverberg and S. Block Uncomplicated Skin and Skin Structure Infections in Children: Diagnosis and Current Treatment Options in the United States Clinical Pediatrics, April 1, 2008; 47(3): 211 - 219. [PDF] |
||||
![]() |
M. A. Drehobl, M. C. De Salvo, D. E. Lewis, and J. D. Breen Single-Dose Azithromycin Microspheres vs Clarithromycin Extended Release for the Treatment of Mild-to-Moderate Community-Acquired Pneumonia in Adults Chest, October 1, 2005; 128(4): 2230 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Athamna, M. Athamna, B. Medlej, D. J. Bast, and E. Rubinstein In vitro post-antibiotic effect of fluoroquinolones, macrolides, {beta}-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis J. Antimicrob. Chemother., April 1, 2004; 53(4): 609 - 615. [Abstract] [Full Text] [PDF] |
||||


